The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer

Aldehyde dehydrogenase 1 (ALDH1) and CD44 have been established as biomarkers for predicting the survival of many types of cancer patients. This study evaluated the expression and clinical significance of these putative cancer-cell markers in a series of tumor samples from endometrial cancer (EC) pa...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Huang, Hsin-Hui, Wang, Yu-Chi, Chou, Yu-Ching, Yu, Mu-Hsien, Chao, Tai-Kuang
Format: Artigo
Language:Inglês
Published: Public Library of Science 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205661/
https://ncbi.nlm.nih.gov/pubmed/30372483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206685
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items